BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11807979)

  • 1. Molecular cytogenetic characterization of non-Hodgkin lymphoma cell lines.
    Mehra S; Messner H; Minden M; Chaganti RS
    Genes Chromosomes Cancer; 2002 Mar; 33(3):225-34. PubMed ID: 11807979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma.
    Nanjangud G; Rao PH; Hegde A; Teruya-Feldstein J; Donnelly G; Qin J; Jhanwar SC; Zelenetz AD; Chaganti RS
    Blood; 2002 Apr; 99(7):2554-61. PubMed ID: 11895793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
    Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
    Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines.
    Harris CP; Lu XY; Narayan G; Singh B; Murty VV; Rao PH
    Genes Chromosomes Cancer; 2003 Mar; 36(3):233-41. PubMed ID: 12557223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual karyotype aberrations involving 2p12, 3q27, 18q21, 8q24, and 14q32 in a patient with non-Hodgkin lymphoma/acute lymphoblastic leukemia.
    Okhowat R; Dorner S; Hinterberger W; Fonatsch C
    Cancer Genet Cytogenet; 2003 Apr; 142(1):60-4. PubMed ID: 12660035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas.
    Cigudosa JC; Parsa NZ; Louie DC; Filippa DA; Jhanwar SC; Johansson B; Mitelman F; Chaganti RS
    Genes Chromosomes Cancer; 1999 Jun; 25(2):123-33. PubMed ID: 10337996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment.
    Offit K; Jhanwar SC; Ladanyi M; Filippa DA; Chaganti RS
    Genes Chromosomes Cancer; 1991 May; 3(3):189-201. PubMed ID: 1868033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations.
    Juneja S; Lukeis R; Tan L; Cooper I; Szelag G; Parkin JD; Ironside P; Garson OM
    Br J Haematol; 1990 Oct; 76(2):231-7. PubMed ID: 2094325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicolor spectral karyotyping of serous ovarian adenocarcinoma.
    Rao PH; Harris CP; Yan Lu X; Li XN; Mok SC; Lau CC
    Genes Chromosomes Cancer; 2002 Feb; 33(2):123-32. PubMed ID: 11793438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping.
    Sawyer JR; Lukacs JL; Munshi N; Desikan KR; Singhal S; Mehta J; Siegel D; Shaughnessy J; Barlogie B
    Blood; 1998 Dec; 92(11):4269-78. PubMed ID: 9834233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping.
    Macville M; Schröck E; Padilla-Nash H; Keck C; Ghadimi BM; Zimonjic D; Popescu N; Ried T
    Cancer Res; 1999 Jan; 59(1):141-50. PubMed ID: 9892199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell non-Hodgkin lymphoma?
    Arcaroli JJ; Dave BJ; Pickering DL; Hess MM; Armitage JO; Weisenburger DD; Sanger WG
    Cancer Genet Cytogenet; 1999 Aug; 113(1):19-24. PubMed ID: 10459341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma.
    Rao PH; Cigudosa JC; Ning Y; Calasanz MJ; Iida S; Tagawa S; Michaeli J; Klein B; Dalla-Favera R; Jhanwar SC; Ried T; Chaganti RS
    Blood; 1998 Sep; 92(5):1743-8. PubMed ID: 9716604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of complex chromosomal abnormalities in B-cell lymphoma by a combined spectral karyotyping (SKY) analysis and fluorescence in situ hybridization (FISH) using a 14q telomere probe.
    Kakazu N; Kito K; Hitomi T; Oita J; Nishida K; Masuda K; Miki T; Abe T
    Am J Hematol; 2000 Dec; 65(4):291-7. PubMed ID: 11074557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four new recurring translocations in non-Hodgkin lymphoma.
    Levine EG; Arthur DC; Machnicki J; Frizzera G; Hurd D; Peterson B; Gajl-Peczalska KJ; Bloomfield CD
    Blood; 1989 Oct; 74(5):1796-800. PubMed ID: 2506953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
    Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
    Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct patterns of chromosome abnormalities characterize childhood non-Hodgkin's lymphoma.
    Mikraki V; Jhanwar SC; Filippa DA; Wollner N; Chaganti RS
    Br J Haematol; 1992 Jan; 80(1):15-20. PubMed ID: 1536806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.
    Wong N; Hui AB; Fan B; Lo KW; Pang E; Leung SF; Huang DP; Johnson PJ
    Cancer Genet Cytogenet; 2003 Jan; 140(2):124-32. PubMed ID: 12645650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets.
    Dyomin VG; Palanisamy N; Lloyd KO; Dyomina K; Jhanwar SC; Houldsworth J; Chaganti RS
    Blood; 2000 Apr; 95(8):2666-71. PubMed ID: 10753849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.